ITMCTR1900002759招募中1 期
Study for metabolic biomarkers of asthmatic children and the therapeutic effect of Xiao-Er Xuan-Fei Ping-Chuan decoction
Affiliated Hospital of Nanjing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 1 至 12(—)
- 性别
- All
入选标准
- •The inclusion criteria of the general observation group:
- •(1) those who meet the diagnostic criteria of Western Medicine issued by the Chinese Academy of Pediatrics for the diagnosis and prevention of children's bronchial asthma (2016 Edition);
- •(2) Aged 1 and 12 years old;
- •(3) informed consent, voluntary subjects. The process of obtaining informed consent shall be in accordance with the provisions of GCP.
- •The inclusion criteria of the treatment group:
- •(1) those who meet the diagnostic criteria of Western Medicine issued by the Chinese Academy of Pediatrics (2016 Edition), the treatment group should meet the syndrome differentiation criteria of traditional Chinese medicine;
- •(2) Aged 1 and 12 years old;
- •(3) those who have acute onset, the condition is mild or moderate according to the above scoring criteria; this asthma attack has not occurred. Use of any relevant treatment drugs;
- •(4) informed consent, voluntary subjects. The process of obtaining informed consent shall be in accordance with the provisions of GCP.
排除标准
- •The exclusion criteria of the general observation group:
- •(1) other diseases that may cause asthma or dyspnea may affect the efficacy judgment;
- •(2) patients with primary diseases such as cardiovascular, cerebrovascular, hepatorenal and hematopoietic system;
- •(3) patients with age less than 1 year and age more than 12 years;
- •(4) patients who are participating in clinical trials of other drugs.
- •The exclusion criteria of the treatment group:
- •(1) stable or in remission stage;
- •(2) severe asthma, asthma status, critical patients, and patients with pulmonary infection;
- •(3) other diseases that may cause asthma or dyspnea may affect the efficacy judgment;
- •(4) patients with primary diseases such as cardiovascular, cerebrovascular, hepatorenal and hematopoietic system;
- •(5) medication not in accordance with the regulations Or the patients who are allergic to the components of this traditional Chinese medicine;
- •(6) the patients whose age is less than 1 year old and more than 12 years old;
- •(7) the patients who are participating in the clinical trials of other drugs.
研究者
相似试验
尚未招募
不适用
The study on metabolic and inflammatory biomarkers and gut microbiota in overweight Thai adultsto investigate and compare the metabolic, inflammatory biomarkers and gut microbiota composition of normal and overweight in a nationally representative sample of Thai adults. Then, associations between will be analysed gut microbial concentrations, clinical-biochemical blood parameters and dietary patterns will be assessed.Overweight, metabolic biomarkers, inflammatory biomarkers, gut microbiota, dietary patternTCTR20220204007Fundamental fund Kasetsart University60
已完成
不适用
Markers of Airway Inflammation in BAL Fluid From Children With AsthmaAsthmaNCT00838552National Jewish Health103
招募中
不适用
Asthma is a very common disease affecting large population. Treatment requires inhalers and hospitilization in severe condition. This treatment is costly. Could use of kitchen spices like clove, black pepper control symptoms of asthma in a better way at a lower costCTRI/2016/12/007589Mittal hospital and research centre200
已完成
不适用
Metabolic Phenotypes in Childhood ObesityObesity, PediatricNCT03014856Hasselt University102
已完成
不适用
A medication education program for children with asthma - a feasibility study.Asthma in childrenRespiratory - AsthmaPublic Health - Health promotion/educationACTRN12614001149651niversity of Sydney80
